Indoco's formulation plant at Baddi - Plant III receives EU GMP certification

Indoco Remedies Ltd. has announced today that it received EU GMP certification from the German Health Authority (Berlin) for its Oral Solid Dosage (OSD) manufacturing facility (Plant III) located at Baddi, Himachal Pradesh. The inspection was carried out from April 22, 2026, to April 27, 2026.

This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive.

Commenting on this development, Ms. Aditi Panandikar, Managing Director - Indoco Remedies Ltd. said, "The EU GMP certification for our formulations manufacturing plant is a testament to our commitment to delivering high quality products to patients across the globe."

Shares of Indoco Remedies Limited was last trading in BSE at Rs. 203.75 as compared to the previous close of Rs. 193.85. The total number of shares traded during the day was 714945 in over 804 trades.

The stock hit an intraday high of Rs. 207.90 and intraday low of 191.00. The net turnover during the day was Rs. 141596238.00.

Source : Equity Bulls

Keywords

IndocoRemedies INE873D01024 Pharmaceuticals EUGMP Certification